This inventor holds 1 USPTO granted patent. Top assignee: Chemagis Ltd.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovations by Huang Anli in Pharmaceutical Chemistry
Introduction
Huang Anli is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His innovative approach has led to the development of a novel process for producing Imatinib, a crucial medication used in cancer treatment.
Latest Patents
Huang Anli holds 1 patent for his work titled "Process for preparing Imatinib." This patent discloses a new method for producing Imatinib using the precursor 2-chloro-4-(3-pyridyl)-pyrimidine. His process improves the preparation of Imatinib by providing an alternative synthetic route that avoids the use of the toxic reagent cyanamide, thereby enhancing safety and efficiency in the production process.
Career Highlights
Huang Anli is currently employed at Chemagis Ltd., where he continues to innovate in the field of drug synthesis. His work has not only contributed to the advancement of pharmaceutical chemistry but has also positioned him as a key figure in the industry.
Collaborations
Huang has collaborated with notable professionals in his field, including Joseph Kaspi and Lior Zelikovitch. These collaborations have further enriched his research and development efforts, leading to more effective solutions in pharmaceutical applications.
Conclusion
Huang Anli's innovative contributions to the synthesis of Imatinib exemplify the impact of creativity and research in the pharmaceutical industry. His work continues to pave the way for safer and more efficient drug production methods.